Mannkind (MNKD) Gross Margin Growth (3y) (2019 - 2026)

Mannkind (MNKD) Gross Margin Growth (3y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 722.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -191.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -162.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -40.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mannkind 1.20 Bn 1.07 Bn 82.66 Mn 528.00

Historic Data

Download Data
DateValue
Mar 31, 2026 528.00
Dec 31, 2025 -112.00
Sep 30, 2025 3,578.00
Jun 30, 2025 7,796.00
Mar 31, 2025 10,133.00
Dec 31, 2024 25,734.00
Sep 30, 2024 1,260.00
Jun 30, 2024 1,120.00
Mar 31, 2024 1,898.00
Dec 31, 2023 15,836.00
Sep 30, 2023 -283.00
Jun 30, 2023 182,775.00
Mar 31, 2023 1,204.00
Dec 31, 2022 1,765.00
Sep 30, 2022 97,289.00
Jun 30, 2022 207,952.00
Mar 31, 2022 -8,310.00
Dec 31, 2021 -23,250.00
Sep 30, 2021 10,150.00
Jun 30, 2021 11,193.00